Karen L Cropsey
University of Alabama at Birmingham
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Registry trials as an overall official
4
all conditions, ClinicalTrials.gov
NIH grants tied to them
11
NIH RePORTER
Trial papers
25
PubMed author-name match
Trials
Studies that name Karen L Cropsey as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:07 UTC. Open this list on ClinicalTrials.gov
- Ph2/Ph3NCT04251819 · Buprenorphine Plus Baclofen to Increase Analgesia in Healthy VolunteersUniversity of Alabama at Birmingham · terminated · Acute Pain, Analgesia · principal investigator
- N/ANCT03968900 · Racial Differences in Circadian and Sleep Mechanisms for Nicotine Dependence, Craving, and WithdrawalUniversity of Alabama at Birmingham · completed · Smoking, Sleep Disturbance, Nicotine Dependence · principal investigator
- Ph2/Ph3NCT03720899 · Comparing NicoBloc to Nicotine LozengesUniversity of Alabama at Birmingham · completed · Smoking Cessation, Nicotine Dependence · principal investigator
- N/ANCT01257490 · Integrated Smoking Cessation Treatment for Low Income Community CorrectionsUniversity of Alabama at Birmingham · completed · Smoking Cessation · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 10:07 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
- A Remote Intervention to Prevent Overdose among People who Use Stimulants and/or OpioidsR61DA065247 · NIDA · UNIVERSITY OF ALABAMA AT BIRMINGHAM · fiscal years 2026 · $447,000 awarded in 2026Same name and institution; not confirmed by an ID
- Medications for opioid use disorder differentially modulate intrinsically photosensitive retinal ganglion cell function, sleep, and circadian rhythms: implications for treatmentR01DA059471 · NIDA · UNIVERSITY OF ALABAMA AT BIRMINGHAM · fiscal years 2023 to 2026 · $1,098,863 awarded in 2026Same name and institution; not confirmed by an ID
- Zambia Alabama HIV Alcohol Comorbidities Program (ZAMBAMA)P01AA029540 · NIAAA · UNIVERSITY OF ALABAMA AT BIRMINGHAM · fiscal years 2021 to 2025 · $1,028,772 awarded in 2025Same name and institution; not confirmed by an ID
- Circadian and sleep mechanisms among racial groups for nicotine dependence, craving, and withdrawalR01DA046096 · NIDA · UNIVERSITY OF ALABAMA AT BIRMINGHAM · fiscal years 2020 to 2024 · $536,155 awarded in 2024Grant number is on one of their registry trials
- Effectiveness of a smoking cessation algorithm integrated into HIV primary careR01DA044112 · NIDA · UNIVERSITY OF ALABAMA AT BIRMINGHAM · fiscal years 2018 to 2022 · $721,940 awarded in 2022Same name and institution; not confirmed by an ID
- 3/3 Alcohol Research Consortium in HIV - Intervention Research Arm (ARCH-IRA)U01AA020802 · NIAAA · UNIVERSITY OF ALABAMA AT BIRMINGHAM · fiscal years 2016 to 2020 · $347,377 awarded in 2020Same name and institution; not confirmed by an ID
- In Vivo Experience with NRT to Increase Adherence and Smoking AbstinenceR01DA039678 · NIDA · UNIVERSITY OF ALABAMA AT BIRMINGHAM · fiscal years 2016 to 2020 · $513,930 awarded in 2020Same name and institution; not confirmed by an ID
- NRT sampling and selection to Increase Medication AdherenceR34DA043346 · NIDA · UNIVERSITY OF ALABAMA AT BIRMINGHAM · fiscal years 2017 to 2019 · $222,750 awarded in 2019Same name and institution; not confirmed by an ID
- Integrated Smoking Cessation Treatment for Low Income Community CorrectionsR01CA141663 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · fiscal years 2009 to 2013 · $247,041 awarded in 2013Grant number is on one of their registry trials
- Relapse prevention to reduce HIV among women prisonersR21DA019838 · NIDA · UNIVERSITY OF ALABAMA AT BIRMINGHAM · fiscal years 2007 to 2008 · $147,796 awarded in 2008Same name and institution; not confirmed by an ID
- Smoking Research With Incarcerated FemalesK23DA015774 · NIDA · UNIVERSITY OF ALABAMA AT BIRMINGHAM · fiscal years 2002 to 2006 · $52,661 awarded in 2006Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 10:07 UTC. The ranking covers the 200 most relevant of 25 PubMed records, and a shared surname and initials can bring in a namesake. All 25 on PubMed
- Modulation of limbic circuitry predicts treatment response to antipsychotic medication: a functional imaging study in schizophrenia.Neuropsychopharmacology · 200996 citationsRCR 2.8
- A test of motivational plus nicotine replacement interventions for HIV positive smokers.AIDS Behav · 200978 citationsRCR 2.7
- Evaluating the effect of access to free medication to quit smoking: a clinical trial testing the role of motivation.Nicotine Tob Res · 201453 citationsRCR 2.3
- A pilot study of screening, brief intervention, and referral for treatment (SBIRT) in non-treatment seeking smokers with HIV.Addict Behav · 201341 citationsRCR 1.6
- Race and Medication Adherence Moderate Cessation Outcomes in Criminal Justice Smokers.Am J Prev Med · 201536 citationsRCR 1.9
- Results of a pilot randomized controlled trial of buprenorphine for opioid dependent women in the criminal justice system.Drug Alcohol Depend · 201132 citationsRCR 1.4
- An Algorithm Approach to Determining Smoking Cessation Treatment for Persons Living With HIV/AIDS: Results of a Pilot Trial.J Acquir Immune Defic Syndr · 201525 citationsRCR 1.0
- A pilot trial of In vivo NRT sampling to increase medication adherence in community corrections smokers.Addict Behav · 201715 citationsRCR 0.8
- The impact of quitting smoking on weight among women prisoners participating in a smoking cessation intervention.Am J Public Health · 201014 citationsRCR 0.5
- Expectancies for the effectiveness of different tobacco interventions account for racial and gender differences in motivation to quit and abstinence self-efficacy.Nicotine Tob Res · 201414 citationsRCR 0.5